Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P B Jensen

Showing results (41-50 of 115) with videos related to

Pageof 12
Sort By:
Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery|October 6, 2000
Repeated digital nerve block for pain control after tenolysisR Kirchhoff, P B Jensen, N S Nielsen, et al.
Cancer Treatment Reviews|January 25, 2000
Twenty-five years of chemotherapy in small cell lung cancer sends us back to the laboratoryP B Jensen, M Sehested, S W Langer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 1999
Inhibitors of topoisomerase II as pH-dependent modulators of etoposide-mediated cytotoxicityS W Langer, G Schmidt, M Sørensen, et al.
Ugeskrift for Laeger|May 31, 1993
[Acute renal failure caused by paracetamol poisoning]C M Pedersen, H B Rasmussen, P B Jensen, et al.
Critical Reviews in Oncology/Hematology|January 1, 1996
Small cell lung cancer: biological and therapeutic aspectsC A Kristensen, P B Jensen, H S Poulsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2000
Dexrazoxane in anthracycline extravasationS W Langer, M Sehested, P B Jensen, et al.
Ugeskrift for Laeger|January 28, 1991
[Bladder tumors in West Lolland. A case-control study of occupational exposure in a risk region]H A Kolstad, N K Jørgensen, S H Hansen, et al.
Biochemical Pharmacology|June 1, 1990
In vitro circumvention of anthracycline--resistance in Ehrlich ascites tumour by anthracycline analoguesE Friche, P B Jensen, H Roed, et al.
Biochemical Pharmacology|September 15, 1989
Daunorubicin and vincristine binding to plasma membrane vesicles from daunorubicin-resistant and wild type Ehrlich ascites tumor cellsM Sehested, N Bindslev, E J Demant, et al.
British Journal of Cancer|January 1, 1997
In vitro cross-resistance and collateral sensitivity in seven resistant small-cell lung cancer cell lines: preclinical identification of suitable drug partners to taxotere, taxol, topotecan and gemcitabinP B Jensen, B Holm, M Sorensen, et al.
Pageof 12

Showing results (41-50 of 115) with videos related to

Sort By:
Pageof 12
Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery|October 6, 2000
Repeated digital nerve block for pain control after tenolysisR Kirchhoff, P B Jensen, N S Nielsen, et al.
Cancer Treatment Reviews|January 25, 2000
Twenty-five years of chemotherapy in small cell lung cancer sends us back to the laboratoryP B Jensen, M Sehested, S W Langer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 1999
Inhibitors of topoisomerase II as pH-dependent modulators of etoposide-mediated cytotoxicityS W Langer, G Schmidt, M Sørensen, et al.
Ugeskrift for Laeger|May 31, 1993
[Acute renal failure caused by paracetamol poisoning]C M Pedersen, H B Rasmussen, P B Jensen, et al.
Critical Reviews in Oncology/Hematology|January 1, 1996
Small cell lung cancer: biological and therapeutic aspectsC A Kristensen, P B Jensen, H S Poulsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2000
Dexrazoxane in anthracycline extravasationS W Langer, M Sehested, P B Jensen, et al.
Ugeskrift for Laeger|January 28, 1991
[Bladder tumors in West Lolland. A case-control study of occupational exposure in a risk region]H A Kolstad, N K Jørgensen, S H Hansen, et al.
Biochemical Pharmacology|June 1, 1990
In vitro circumvention of anthracycline--resistance in Ehrlich ascites tumour by anthracycline analoguesE Friche, P B Jensen, H Roed, et al.
Biochemical Pharmacology|September 15, 1989
Daunorubicin and vincristine binding to plasma membrane vesicles from daunorubicin-resistant and wild type Ehrlich ascites tumor cellsM Sehested, N Bindslev, E J Demant, et al.
British Journal of Cancer|January 1, 1997
In vitro cross-resistance and collateral sensitivity in seven resistant small-cell lung cancer cell lines: preclinical identification of suitable drug partners to taxotere, taxol, topotecan and gemcitabinP B Jensen, B Holm, M Sorensen, et al.
Pageof 12